Editorial: Rising stars in cancer metabolism 2022

Editorial: Rising stars in cancer metabolism 2022

Bibliographic Details
Main Authors:	Jose Luis Izquierdo-Garcia, Domenica Scumaci
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Oncology
Subjects:	metabolic reprogramming metabolic symbiosis glutamine metabolism metabolism and redox homeostasis metabolism and chemoresistance personalized medicine
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1223630/full

Similar Items

The role of metabolic reprogramming in pancreatic cancer chemoresistance
by: Chang Liu, et al.
Published: (2023-01-01)

Editorial: Redox metabolism: a double edge sword sustaining the adaptive resistance to therapy in cancer
by: Barbara Marengo, et al.
Published: (2023-08-01)

Editorial: Metabolic reprogramming in breast cancer
by: Cristian Scatena, et al.
Published: (2022-11-01)

Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
by: Xun Chen, et al.
Published: (2020-07-01)

Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance
by: Dimas Carolina Belisario, et al.
Published: (2020-12-01)

Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment
by: Guofeng Ma, et al.
Published: (2022-07-01)

Metabolomic analysis of rat arterial serum under hypobaric hypoxia: Adaptive regulation of physiological systems by metabolic reprogramming
by: Dengqin Ma, et al.
Published: (2025-03-01)

Epigenetic meets metabolism: novel vulnerabilities to fight cancer
by: Domenica Scumaci, et al.
Published: (2023-09-01)

Metabolic Dependencies in Pancreatic Cancer
by: Ali Vaziri-Gohar, et al.
Published: (2018-12-01)

Corrigendum: Metabolic Dependencies in Pancreatic Cancer
by: Ali Vaziri-Gohar, et al.
Published: (2019-01-01)

Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemia
by: Lili Feng, et al.
Published: (2023-09-01)

Inhibition of asparagine synthetase effectively retards polycystic kidney disease progression
by: Sara Clerici, et al.
Published: (2024-04-01)

Glutamine Metabolism in Prostate Cancer
by: Xuguang Guo
Published: (2024-08-01)

Glutamine metabolic reprogramming in hepatocellular carcinoma
by: Yanyan Ye, et al.
Published: (2023-08-01)

Metabolic Plasticity in Chemotherapy Resistance
by: Maria Andrea Desbats, et al.
Published: (2020-03-01)

4-Hydroxyphenylpyruvate Dioxygenase-Like Protein Promotes Pancreatic Cancer Cell Progression and Is Associated With Glutamine-Mediated Redox Balance
by: Xianglai Ye, et al.
Published: (2021-01-01)

Molecular Insights in the Anticancer Activity of Natural Tocotrienols: Targeting Mitochondrial Metabolism and Cellular Redox Homeostasis
by: Raffaella Chiaramonte, et al.
Published: (2025-01-01)

Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets
by: Xuewei Zheng, et al.
Published: (2022-12-01)

Increased Ammonium Toxicity in Response to Exogenous Glutamine in Metastatic Breast Cancer Cells
by: Violet A. Kiesel, et al.
Published: (2022-05-01)

Metabolic reprogramming induced by DCA enhances cisplatin sensitivity through increasing mitochondrial oxidative stress in cholangiocarcinoma
by: Hanjiao Qin, et al.
Published: (2023-09-01)

Glucose Favors Lipid Anabolic Metabolism in the Invasive Breast Cancer Cell Line MDA-MB-231
by: Mª Carmen Ocaña, et al.
Published: (2020-01-01)

Editorial: Reviews in cancer metabolism
by: Nadia Jacobo-Herrera, et al.
Published: (2023-03-01)

Peroxisomal homeostasis in metabolic diseases and its implication in ferroptosis
by: Jiwei Han, et al.
Published: (2024-10-01)

Targeting hypoxic tumor microenvironment in pancreatic cancer
by: Jinxin Tao, et al.
Published: (2021-01-01)

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
by: Rui Ni, et al.
Published: (2023-03-01)

Editorial: Reviews in cancer metabolism: 2023
by: Bela Ozsvari, et al.
Published: (2024-09-01)

CAFs targeted ultrasound-responsive nanodroplets loaded V9302 and GLULsiRNA to inhibit melanoma growth via glutamine metabolic reprogramming and tumor microenvironment remodeling
by: Chen Ai, et al.
Published: (2023-07-01)

Neutrophil extracellular traps in tumor metabolism and microenvironment
by: Zhanrui Liu, et al.
Published: (2025-01-01)

Therapeutic Potential of Glutamine Pathway in Lung Cancer
by: Enyu Tang, et al.
Published: (2022-02-01)

Metabolic Symbiosis in Chemoresistance: Refocusing the Role of Aerobic Glycolysis
by: Lisi Ma, et al.
Published: (2020-01-01)

VDAC Modulation of Cancer Metabolism: Advances and Therapeutic Challenges
by: Kareem A. Heslop, et al.
Published: (2021-09-01)

The Role and Therapeutic Perspectives of Sirtuin 3 in Cancer Metabolism Reprogramming, Metastasis, and Chemoresistance
by: QingYi Zhao, et al.
Published: (2022-06-01)

Nanotechnology-based tumor metabolic reprogramming: Insights into nutrient-delivery and metabolism reactivation therapy
by: Xi Hu, et al.
Published: (2024-10-01)

The Role of Aberrant Metabolism in Cancer: Insights Into the Interplay Between Cell Metabolic Reprogramming, Metabolic Syndrome, and Cancer
by: Yina Yu, et al.
Published: (2020-06-01)

Breast Cancer Cell Subtypes Display Different Metabolic Phenotypes That Correlate with Their Clinical Classification
by: Consuelo Ripoll, et al.
Published: (2021-12-01)

Metabolic Reprogramming, Questioning, and Implications for Cancer
by: Pierre Jacquet, et al.
Published: (2021-02-01)

Lactate-induced MRP1 expression contributes to metabolism-based etoposide resistance in non-small cell lung cancer cells
by: Qi Dong, et al.
Published: (2020-10-01)

Influence of Inflammation in the Process of T Lymphocyte Differentiation: Proliferative, Metabolic, and Oxidative Changes
by: Marco A. Moro-García, et al.
Published: (2018-03-01)

How neutrophil metabolism affects bacterial killing
by: Juliana E. Toller-Kawahisa, et al.
Published: (2022-11-01)

Metabolism-Related Prognostic Biomarkers, Purine Metabolism and Anti-Tumor Immunity in Colon Adenocarcinoma
by: Hui Liu, et al.
Published: (2023-12-01)